More ALS genes identified, expanding the foundation for treatment development
Researchers from Project MinE have identified new genetic abnormalities that play a role in the development of ALS. As a result, the proportion of patients for whom a genetic cause can be identified of the neuromuscular disease has increased from 20 to 25 percent. The discovery also improves understanding of the disease and may, in time, support the development of targeted treatments for a subset of patients.
